SILVERCREST ASSET MANAGEMENT GROUP LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 110 filers reported holding TRANSMEDICS GROUP INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q1 2023$5,483,231
+0.1%
72,405
-18.4%
0.04%0.0%
Q4 2022$5,477,156
-3.0%
88,742
-34.4%
0.04%
-8.7%
Q3 2022$5,647,000
+29.2%
135,293
-2.6%
0.05%
+39.4%
Q2 2022$4,370,000
-39.6%
138,959
-48.3%
0.03%
-29.8%
Q1 2022$7,240,000
+41.9%
268,753
+0.9%
0.05%
+46.9%
Q4 2021$5,101,000
-25.1%
266,231
+29.4%
0.03%
-30.4%
Q3 2021$6,807,000205,7240.05%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders